Cargando…
Coronavirus disease 2019 associated with aggressive neurological and mental abnormalities confirmed based on cerebrospinal fluid antibodies: A case report
INTRODUCTION: Coronavirus disease (COVID-19) is spreading worldwide. The reported possible neurological symptoms are varied and range from subtle neurologic deficits to unconsciousness. Knowledge regarding the detection, diagnosis, treatment, and follow-up of COVID-19-associated neurological damage...
Autores principales: | Wang, Maomao, Li, Ting, Qiao, Fan, Wang, Laixing, Li, Chunlin, Gong, Yanping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478433/ https://www.ncbi.nlm.nih.gov/pubmed/32898993 http://dx.doi.org/10.1097/MD.0000000000021428 |
Ejemplares similares
-
Cerebrospinal fluid and blood levels of neurofilament light chain in Parkinson disease: A protocol for systematic review and meta-analysis
por: Wang, HongZhou, et al.
Publicado: (2020) -
CXCL13 and TH1/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients
por: Yan, Yongxing, et al.
Publicado: (2017) -
Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficit
por: Yu, Zhenwei, et al.
Publicado: (2021) -
Apoptosis in cerebrospinal fluid as outcome predictors in severe traumatic brain injury: An observational study
por: Jiang, Wenqing, et al.
Publicado: (2020) -
Neurofilament light chain in cerebrospinal fluid or blood as a biomarker for mild cognitive impairment: A systematic review and meta-analysis
por: Zhang, Jing, et al.
Publicado: (2022)